Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Hldgs LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.50p -3.17% 15.25p 15.00p 15.50p 15.75p 15.25p 15.75p 195,132 11:00:01
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -3.0 -1.1 - 39.89

Scancell Hldgs (SCLP) Latest News

More Scancell Hldgs News
Scancell Hldgs Takeover Rumours

Scancell Hldgs (SCLP) Share Charts

1 Year Scancell Hldgs Chart

1 Year Scancell Hldgs Chart

1 Month Scancell Hldgs Chart

1 Month Scancell Hldgs Chart

Intraday Scancell Hldgs Chart

Intraday Scancell Hldgs Chart

Scancell Hldgs (SCLP) Discussions and Chat

Scancell Hldgs Forums and Chat

Date Time Title Posts
22/10/201614:04Using immunology to fight cancer.7,092
16/10/201620:04Scancell short thread1
16/9/201614:20Could this be the end of cancer?750
16/8/201408:47Using immunology to fight cancer (LTH W/O Rose Tints - Free Speech Thread)161

Add a New Thread

Scancell Hldgs (SCLP) Most Recent Trades

No Trades
Trade Time Trade Price Trade Size Trade Value Trade Type
View all Scancell Hldgs trades in real-time

Scancell Hldgs (SCLP) Top Chat Posts

Scancell Hldgs Daily Update: Scancell Hldgs is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell Hldgs was 15.75p.
Scancell Hldgs has a 4 week average price of 15.79p and a 12 week average price of 17.22p.
The 1 year high share price is 24.50p while the 1 year low share price is currently 12p.
There are currently 261,558,099 shares in issue and the average daily traded volume is 295,296 shares. The market capitalisation of Scancell Hldgs is £39,887,610.10.
panama7: Knowlesi/Tosh, forgot to add this other gem from Goodfellow " people have been coming up to me and saying hey Richard you may have found a cure for Cancer". So he may have found a cure for Cancer that is worth 150m shares at 15p. Knowlesi the point is he has done nothing whatsoever to support the share price , he has failed to live up to any statements made so has actually had a detrimental effect on the share price and investors portfolio for 3 years. In the Hardman report it does a peer comparison look how far behind our competitors we are in market cap, that is down to Goodfellow's lame performance.
j777j: Interesting report pointing out Scancell's nearest competitor with only one product is valued 13 times higher.That puts a 195p share price in Scancell.Food for thought and worth a few in the bottom drawer,just in case.
fragma: Lol agema, or maybe the next week, or maybe the week after that. Whats wrong with you guys, that you cant stand to see the share price rise ! Cheer up, and maybe even buy SOME shares. It might even put a smile on your face for a change instead of spending all day on here praying for the share price to drop
inanaco: Boom, In fairness if they had of raised all the funding at 17p,(inc. trails) then yes i would have flipped, ... They did not, as you rightly suggested before the cash call, that they may raise a small amount. so happy with the position we are in, because of the ISA. I still have 100,000 shares outside my tax haven so long term the benefit of those in the ISA now are going to yield a huge tax free bonus, and in fairness when i started investing in Scancell there was NO ISA for AIM, so its an added bonus which i did not expect. so you say i would not be happy at 16p .... well I am for the simple reason that it allows me to buy more than i expected. Its all about "confidence" in what we have ...The science Not the share price which i have no control over. would i sell at this level, No would i buy at this level, Yes do i "need" to sell at this level NO ...if i did, i would not be happy. would the share price stop a deal being done, No would the share price be any different today after a deal than a deal done 3 years ago ??? YES a huge amount of data has been added, so IMHO I dont see the difference providing i can see "asset" growth within Scancell. Just because the market does not see that IE the SP, it does not mean that it has not. The market works on sentiment, just like every other market. so the question is ... Why would the OIL price go up recently even thou the supply side still exceeds the demand side... answer, based on sentiment of a deal at Opec ... has the Supply side of vaccines in the adjuvant setting for Melanoma increased ? NO so what has changed to warrant the Current Shareprice ..? when we know full well that the results are not published yet. it was crazy of "us" to think that Scancell would sell us short by doing a deal before all the data is in . that is the mistake we made, Not Scancell.
panama7: Boom 10:06, yes I have read many positive RNS's regarding the science but not one positive RNS regarding the commercial side. As for short term share price do you consider 3 years of a sliding share price to be short term. There is absolutely no correlation between the share price and the messages coming from the BOD. If you took everything the BOD have stated over the last three years you would expect to see a share chart that sees an share price continuing to rise.
tosh123: Come on.... he's called many things right over the last few years, just look at his track record... It speaks for itself ! .. Theres the infamous " £1 tomorrow " quote, and the " We're minted " quote. This was used for many months if not years, when the share price was at least double what it is today... Theres the " they cant make any more to sell any more " quote, just around the time of the last OO .. Theres the " this is less risky than drinking a glass of water " quote, as the share price tumbled from about 40p ... Theres the " you wouldn't want to be out of this " quote, when these were trading at circa 40p a few years ago... Theres the legendary " big news is coming in the next few days " quote, once again when the share price was way in excess of 30p, and what happened ? Well there was no news at all, and the share price continued to fall ! .. I can go on, because theres so many of them... The guy has called everything wrong 100% of the time. The only thing he is, is consistent .
inanaco: So lets look at the share price if there is a majority staying out of Scancell so that they can benefit if the Funding is done below current share price ...then that would account for the subdued SP lets say there is a cash call at a Premium lets pick a number 79p what will the share price open at ?
inanaco: tosh123 Posts: 2,474 Off Topic Opinion: No Opinion Price: 17.00 knowlesi Today 10:59 I agree.... funding will almost certainly be in place, which reinforces the question, why didnt they include that information in the RNS ? You make a very logical suggestion, in that the financiers may not wish their identities to be disclosed yet, this is indeed possible, but even then, a simple " these trials are already fully funded, details to follow " would have been a more reasonable way of dealing with matters, rather than just avoiding any questions or discussions on the subject. """""I reiterate, although the names now associated with the trial are impressive, it still remains that one cannot assess how these trials will impact on the financial stability of the company, until details of funding are announced.""""""" -------------------------- You seem to have missed the point Tosh .. the academics have Rubber Stamped SCIB1 results......... which places enormous value on the ASSET and has nothing to do with the share Price, Scancell can raise funds with that asset with ease. Educated Folk in the US have a club ..... Scancell is now in that Club. All i can say is you have got Scancell completely wrong, its not our fault you forgot to buy the share at the bottom. Along with Agema and Dutchgold ... you seem to have become share less. So what is market value of SCIB1 now ... over $500m ... go an compare the market Problem you have nobody has ever achieved the results of Scancell without toxicity ... Its number 1 in its field .. The value will become evident over the next 3 to 6 months, all about the number you hold not the number you dont. as i have posted before Scancell is raising funds for a project this has nothing to do with the share price. The markets obsession with sentiment is why it gets it wrong ... The smart folks only look at the science and the real world market deals .. Do that and the share price goes straight over a £1 ... simple stuff, the data has been presented many times as to why it should be so .. what gets in the way AIM Sentiment.
inanaco: if you search back you will find my posts ref Scancell has no interest in the share price and this goes before any major fall. like wise i have said it many times, that a low share price is great for people like me, as we benefit from low top ups. the share price is all about how many you hold when the music stops, and Goy is not the DJ this time. so you SB the "clever" one, seem to think that attacking me over the share price is clever, actually if you read my history it makes not one bit of difference. so who is smart.. ?
djt59: Allocations will be different depending on which nominee pool you are part of. Selftrade gave me all I requested, might be because my request was smaller than many, or maybe there were enough holders using Selftrade that didn't request their allocation that those that did got what we requested. My initial interest in SCLP came via long-time holding in OXT, I then bought some more OXT and some SCLP, then when SCLP had the price crash but OXT didn't I sold most OXTs to buy SCLP. OXT has about 18p of NAV from other holdings and has the VCT tax advantage, but it will also have a 20% management incentive fee (above a certain return, but effectively on everything if SCLP pans out nicely) and I reckon the effective NAV multiplier to get OXT NAV from SCLP price is now just a whisker above one (so the OXT NAV is simply the SCLP share price plus approx 18p, with no adjustment for tax consequences). Now there is the SCLP ISA-AIM and possibly EIS tax advantage. So, depending on your holding size and maybe CG losses to carry forward, it seems to me that having over double the number of original OXT shares as SCLP shares is a good outcome! And I was lucky to have bought SCLP before the OO qualification date! [Although they did cost me more than the current price.]
Scancell Hldgs share price data is direct from the London Stock Exchange
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20161022 19:50:33